The prevalence of metabolic syndrome in patient with psoriasis
Journal Title: IP Indian Journal of Clinical and Experimental Dermatology - Year 2018, Vol 4, Issue 1
Abstract
Introduction Psoriasis is a chronic relapsing remitting skin disease with T cell mediated inflammatory response The presence of increased no of proinflammatory cytokines leads to increase the risk of development of metabolic disease and CVD in patient with psoriasisAim To find the prevalence of metabolic syndrome in patient with psoriasisMethods This study was a prospective hospital based case control study including 194 cases of psoriasis and 194 healthy matched controls Waist circumference was obtained Serum Triglycerides and cholesterol were measured using standard procedure Venous samples were collected from the patients after overnight fasting at least 8 h Blood pressure was then recorded Patient was labelled with metabolic syndrome when three of the five mentioned parameters were abnormal according to the criteria of the SAM National Cholesterol Education Programs Adult Treatment Panel III ATPIIIResults There were 117 males 60 and 77 females 397 in study group while 127 males 655 and 67 females 345 in control group Metabolic Syndrome was present in 428 of cases compared 232 of controls with a p value lt005 fasting blood sugar level was significantly higher among those with MS 469 compared to 242 in control groupConclusion The increased frequency of metabolic syndrome in patient with psoriasis led to a great burden not only on the health but also to the treating physician All psoriasis patients must be screened for metabolic syndrome at the very onset of disease to decrease the comorbidities associated with psoriasisKeywords Triglycerides Metabolic syndrome Psoriasis
Authors and Affiliations
Manu Singh, Manjinder Singh
Keywords
Related Articles
- EP ID EP488946
- DOI 10.18231/.2018.0007
- Views 87
- Downloads 0
Quality of Life of Patients with Psoriasis Seeking Care from Out Patient Department (OPD) of a Tertiary Care Centre of South India Assessed by Dermatology Life Quality Index (DLQI) and its Correlation with Psoriasis Area Severity Index (PASI)
Introduction: Psoriasis causes considerable psychosocial disability and has a major impact on patients’ quality of life. A proper assessment of the quality of life may help the doctor to individualize the treatment plan...
Imatinib mesylate induced erythroderma: A rare case report
Imatinib, a specific tyrosine kinase inhibitor is a newer anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is generally well tolerated with few side effects. Most commonly rep...
Comparative study of percutaneous collagen induction therapy and dermabrasion on post acne scars
Introduction: Acne is a self-limiting disease of pilosebaceous unit seen predominantly in adolescence, clinically characterized by papules, pustules, comedones, nodules and cysts and may result in scarring. Aim and Objec...
Evaluation of clinical response and efficiency of laser treatment for removing or significantly improving in facial nevi in north Indian population
Introduction Melanocytic nevus is commonly occurring condition in Indian subjects We investigate the clinical response and efficiency of laser for removing facial melanocytic neviMaterials and Methods The present study c...
A study of cutaneous adverse drug reaction patterns with causality and severity assessment at a tertiary care centre
Introduction Prescribed medications are intended to relieve sufferings during the course of illness Occasionally due to the unpredictable pharmacological nature of the drug the unique physiological condition of the patie...